Indies Pharma Jamaica Limited (JMSE:INDIES)

Indies Pharma Jamaica Revenue

In the fiscal year ending October 31, 2025, Indies Pharma Jamaica had annual revenue of 1.13B JMD, down -2.72%. Indies Pharma Jamaica had revenue of 271.54M in the quarter ending October 31, 2025, a decrease of -6.92%.

• Revenue: 1.13B
• Revenue Growth: -2.72%
• P/S Ratio: 3.34
• Revenue / Employee: n/a
• Employees: 65
• Market Cap: 3.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	1.13B	-31.54M	-2.72%
Oct 31, 2024	1.16B	103.52M	9.81%
Oct 31, 2023	1.06B	118.18M	12.61%
Oct 31, 2022	937.28M	90.45M	10.68%
Oct 31, 2021	846.83M	80.88M	10.56%